Fig. 2 A

Ismail T et al. (2024)

Xla Wt +PFOS

NF35/36 (in situ hybridization)

Expression Phenotype

increased amount pax6.L expression in eye
increased amount pax6.L expression in forebrain
increased amount pax6.L expression in hindbrain
increased amount pax6.L expression in midbrain-hindbrain boundary
increased amount pax6.L expression in olfactory region
increased amount ldlrap1.L expression in liver primordium
increased amount nkx2-5.L expression in heart
increased amount sox3.L expression in forebrain
increased amount sox3.L expression in midbrain-hindbrain boundary

Fig. 3. B

O'Brien MP et al. (2023)

Xtr Wt + smc5 CRISPR

NF28 (in situ hybridization)

Expression Phenotype
decreased amount pax6 expression in brain decreased amount pax6 expression in eye primordium decreased amount pax6 expression in spinal cord

Fig. S3A r2c1-4

Job F et al. (2023)

Xla Wt + otud3 MO1/2

NF35/36 (in situ hybridization)

Anatomical Phenotype
abnormal eye morphology abnormal head morphology

Expression Phenotype
decreased amount pax6.L expression in forebrain mislocalised pax6.L expression in retina

Fig.6.E-F

Hantel F et al. (2022)

Xla Wt + rmnd5a MO

NF32 (in situ hybridization)

Anatomical Phenotype
abnormal brain abnormal eye decreased size of the eye

Expression Phenotype
decreased amount pax6.L expression in brain decreased amount pax6.L expression in eye

No Image

Fig. 3CD

Flach H et al. (2022)

Xla Wt + glyphosate [121.5]

NF23 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in eye decreased amount rax.L expression in eye

No Image

Fig. 3B

Flach H et al. (2022)

Xla Wt + glyphosate [243]

NF13 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in eye primordium decreased amount rax.L expression in eye primordium decreased amount sox3.L expression in eye primordium

No Image

Fig. 3CD

Flach H et al. (2022)

Xla Wt + glyphosate [243]

NF23 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in eye decreased amount rax.L expression in eye

Fig. 3A

Delhermite J et al. (2022)

Xla Wt + fbl MO

NF32 (in situ hybridization)

Expression Phenotype
decreased amount pax6.L expression in brain decreased amount pax6.L expression in hindbrain decreased amount hes4.L expression in branchial arch decreased amount hes4.L expression in pharyngeal arch decreased amount twist1.L expression in branchial arch decreased amount twist1.L expression in pharyngeal arch

Fig.S1.C

Pokrovsky D et al. (2021)

Xla Wt + hydroxyurea + aphidicolin

NF32 (RT-PCR)

Expression Phenotype
decreased amount pax6.L expression in embryo

XB-PHENO-25421

Flach H et al. (2021)

Xla Wt + rbp1 MO1

NF13

Expression Phenotype
decreased amount pax6.L expression in optic field decreased amount rax.L expression in optic field mislocalised sox3.L expression in optic field